Results 211 to 220 of about 859,419 (358)

Silver Nanoparticle‐Mediated Antiviral Efficacy against Enveloped Viruses: A Comprehensive Review

Global Challenges, EarlyView.
Silver nanoparticles (AgNPs) exhibit broad‐spectrum antiviral activity by targeting key viral structures and processes. They disrupt viral envelopes, compromising integrity, and bind to nucleocapsids, impairing viral replication. AgNPs also inhibit glycoprotein interactions, preventing viral attachment and entry into host cells.
Ekaterine Mosidze, Gianluigi Franci, Federica Dell'Annunziata, Nicoletta Capuano, Marica Colella, Flora Salzano, Massimiliano Galdiero, Aliosha Bakuridze, Veronica Folliero   +8 more
wiley   +1 more source

Post COVID‐19 vaccination: AusVaxSafety survey participation and adverse events – a community‐based regional Queensland study

Australian and New Zealand Journal of Public Health, Volume 46, Issue 6, Page 738-744, December 2022., 2022
Abstract Objective: To describe adverse events following COVID‐19 immunisation (AEFI) and participation in AusVaxSafety surveillance in a Queensland regional community. Methods: Participants presenting for second dose COVID‐19 vaccine at the Hervey Bay Wide Bay Hospital and Health Service (WBHHS) vaccine clinic in July 2021 completed a survey ...
Elizabeth Hamilton, Shannen Oversby, Scott Kitchener, Angela Ratsch   +3 more
wiley   +1 more source

Importance of Antigenic Composition of Influenza Virus Vaccine in Protecting against the Natural Disease

, 1949
Jonas Salk, Philip C. Suriano
openalex   +2 more sources

VACCINES FOR INFLUENZA [PDF]

BMJ, 1918
openaire   +3 more sources

Rapid on‐site molecular Point of Care Testing during influenza outbreaks in aged care facilities improves antiviral use and reduces hospitalisation

Australian and New Zealand Journal of Public Health, Volume 46, Issue 6, Page 884-888, December 2022., 2022
Abstract Objective: Western Sydney Local Health District (WSLHD) measured the utility and validity of rapid molecular point‐of‐care testing (POCT) in aged care facilities (ACFs) experiencing influenza‐like illness (ILI) outbreaks against routine laboratory testing.
Elizabeth Escarate, Christian G. Jones, Elizabeth Clarke, Penelope Clark, Sophie Norton, Shopna Bag, Jen Kok, Dominic E. Dwyer, Richard I. Lindley, Robert Booy   +9 more
wiley   +1 more source

Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine [PDF]

, 1972
H. Z�vadov�, Vladim�r Vonka, Ervin Adam, Eva Domor�zkov�, Fred M. Davenport   +4 more
openalex   +1 more source

Vitamin D—A prominent immunomodulator to prevent COVID‐19 infection

International Journal of Rheumatic Diseases, Volume 26, Issue 1, Page 13-30, January 2023., 2023
Abstract COVID‐19 remains a life‐threatening infectious disease worldwide. Several bio‐active agents have been tested and evaluated in an effort to contain this disease. Unfortunately, none of the therapies have been successful, owing to their safety concerns and the presence of various adverse effects.
Sumel Ashique, Kirti Gupta, Gaurav Gupta, Neeraj Mishra, Sachin Kumar Singh, Sheetu Wadhwa, Monica Gulati, Harish Dureja, Flavia Zacconi, Brian G. Oliver, Keshav Raj Paudel, Philip M. Hansbro, Dinesh Kumar Chellappan, Kamal Dua   +13 more
wiley   +1 more source

Placebo-controlled double-blind clinical studies on the efficacy of different influenza vaccines assessed by experimental and natural infection [PDF]

, 1976
Francis André, P Uytterschaut, I Niculescu, G Virlan, E Zilişteanu, S Smerdel, I Vodopija   +6 more
openalex   +1 more source

The Future Hospital in Global Health Systems: The Future Hospital Within the Healthcare System

The International Journal of Health Planning and Management, EarlyView.
ABSTRACT Future hospitals must be able to adapt in many ways to the changing demands on their roles and functions within evolving healthcare delivery infrastructures. These include changing population structures and needs, new models of healthcare provision, technological advances, and innovations in design, all while enhancing their environmental ...
N. J. Sebire, A. Adams, L. Celi, A. Charlesworth, M. Gorgens, M. Gorsky, O. Landeg, Y. Nagasawa, K. T. Nimako, C. Onoka, S. Roder‐DeWan, N. Watts, M. McKee   +12 more
wiley   +1 more source

A novel genotyping system based on site polymorphism on spike gene reveals the evolutionary pathway of porcine epidemic diarrhea virus

iMetaOmics, EarlyView.
This study focuses on porcine epidemic diarrhea virus (PEDV), a highly virulent and rapidly evolving coronavirus threatening global swine production. We established a novel genotype system of PEDV targeting site‐specific polymorphisms in the spike (S) protein.
Mingkai Lei, Huimin Li, Xiaoyu Chen, Xiaozhen Li, Xuexiang Yu, Shengnan Ruan, Hao Wu, Ahmed H. Ghonaim, Ziyang Yan, Wentao Li, Qigai He   +10 more
wiley   +1 more source